192 related articles for article (PubMed ID: 32612367)
1. The Anti-Tumor Effect of Nab-Paclitaxel Proven by Patient-Derived Organoids.
Xiao X; Chen W; Wei ZW; Chu WW; Lu XF; Li B; Chen H; Meng SJ; Hao TF; Wei JT; He YL; Zhang CH
Onco Targets Ther; 2020; 13():6017-6025. PubMed ID: 32612367
[TBL] [Abstract][Full Text] [Related]
2. Establishment of gastric cancer organoid and its application in individualized therapy.
Miao X; Wang C; Chai C; Tang H; Hu J; Zhao Z; Luo W; Zhang H; Zhu K; Zhou W; Xu H
Oncol Lett; 2022 Dec; 24(6):447. PubMed ID: 36420067
[TBL] [Abstract][Full Text] [Related]
3. Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer.
Zhu M; Zhang P; Yu S; Tang C; Wang Y; Shen Z; Chen W; Liu T; Cui Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):14. PubMed ID: 34996504
[TBL] [Abstract][Full Text] [Related]
4. Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.
Zhang C; Awasthi N; Schwarz MA; Hinz S; Schwarz RE
PLoS One; 2013; 8(2):e58037. PubMed ID: 23460921
[TBL] [Abstract][Full Text] [Related]
5. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
6. An Organoid-Based Preclinical Model of Human Gastric Cancer.
Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
[TBL] [Abstract][Full Text] [Related]
7. Organoids From Mucinous Appendiceal Adenocarcinomas as High-Fidelity Models for Individual Therapy.
Liu G; Xiao X; Xia Y; Huang W; Chen W; Xu J; Chen S; Wang H; Wei J; Li H; Shu M; Lu X; Zhang C; He Y
Front Med (Lausanne); 2022; 9():829033. PubMed ID: 35721089
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
[TBL] [Abstract][Full Text] [Related]
9. SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids.
Roy S; Dukic T; Keepers Z; Bhandary B; Lamichhane N; Molitoris J; Ko YH; Banerjee A; Shukla HD
Cell Death Discov; 2024 Mar; 10(1):106. PubMed ID: 38429272
[TBL] [Abstract][Full Text] [Related]
10. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of organoids from a patient with adenomyoepithelioma of the breast.
Luo X; She J; Xu T; Zhou Y; Xu C; Jiang J; Li T; Liu H; Shen H; Yin B; Dai B
Bioengineered; 2021 Dec; 12(2):11578-11585. PubMed ID: 34874791
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and preliminary application of organoids in ovarian cancer].
Zhang L; Meng HY; Zhang YS; Miao HX; Yuan L; Zhou SL; Jiang Y; Wan YC; Cheng WW
Zhonghua Fu Chan Ke Za Zhi; 2023 Feb; 58(2):112-120. PubMed ID: 36776006
[No Abstract] [Full Text] [Related]
13. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid.
Tanaka C; Furihata K; Naganuma S; Ogasawara M; Yoshioka R; Taniguchi H; Furihata M; Taniuchi K
Hum Cell; 2022 Mar; 35(2):735-744. PubMed ID: 35150409
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient-Derived Xenografts and Mesothelin as a Biomarker of Tumor Response.
Zhang J; Khanna S; Jiang Q; Alewine C; Miettinen M; Pastan I; Hassan R
Clin Cancer Res; 2017 Mar; 23(6):1564-1574. PubMed ID: 27635089
[No Abstract] [Full Text] [Related]
15. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG
J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
[TBL] [Abstract][Full Text] [Related]
17. Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell.
Ukai S; Honma R; Sakamoto N; Yamamoto Y; Pham QT; Harada K; Takashima T; Taniyama D; Asai R; Fukada K; Naka K; Tanabe K; Ohdan H; Yasui W
Oncogene; 2020 Dec; 39(50):7265-7278. PubMed ID: 33046798
[TBL] [Abstract][Full Text] [Related]
18. S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model.
Suenaga M; Yamada S; Fujii T; Tanaka C; Kanda M; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
J Surg Oncol; 2016 Mar; 113(4):413-9. PubMed ID: 27100026
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model.
Li X; Pan B; Song X; Li N; Zhao D; Li M; Zhao Z
Cancer Cell Int; 2020; 20():86. PubMed ID: 32206037
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of
Awasthi N; Schwarz MA; Zhang C; Schwarz RE
Mol Cancer Ther; 2018 Nov; 17(11):2353-2364. PubMed ID: 30166402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
